Cannara Biotech Inc. (LOVFF) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Cannara Biotech Inc.

LOVFF

PNK

92M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 Jul 2025

92M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 Jul 2025

1.01USD

0.02 ( 2.02%)

Market Open

Relative Strenght

Volume Buzz

-56%

Earning Acce

Dist 52w H.

Overview Chart

Quote Panel

Updated April 26, 2025

1W 4.99 % 1M 9.78 % 3M 53.03 % 1Y 71.89 %

Key Metrics

Market Cap
91.55M
Shares Outstanding
90.64M
Share in Float
43.54M
Dividende
0

Earning Date
21 Jul 2025
Price Target
1.01
Average Volume
7452
Beta
0.795

Range
0.387-1.02
Industry
Drug Manufacturers - Specialty & Generic
Website
https://cannara.ca
Sector
Healthcare

Quote Panel

Updated April 26, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

15.61x

P/E Ratio

1.45x

P/S Ratio

1.39x

P/B Ratio

0.5

Debt/Equity

7.6%

Net Margin

$0.1

EPS

How LOVFF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

LOVFF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q3.22

+126%

0.03
vs 0.01

Q4.22

+421%

0.02
vs -0.01

Q1.23

N/A

-0.01
vs -0.01

Q2.23

+105%

0.03
vs 0.02

Q3.23

+76%

0.05
vs 0.03

Q4.23

+19%

0.02
vs 0.02

Q1.24

N/A

-0.04
vs -0.01

Q2.24

-34%

0.02
vs 0.03

Q3.24

+23%

0.06
vs 0.05

Q4.24

-22%

0.02
vs 0.02

Sales Growth

YoY

Current

Estimates

Q3.22

+89%

11.8M vs 6.2M

Q4.22

+57%

10.3M vs 6.6M

Q1.23

+76%

13M vs 7.4M

Q2.23

+57%

15.8M vs 10.1M

Q3.23

+55%

18.3M vs 11.8M

Q4.23

+89%

19.5M vs 10.3M

Q1.24

+51%

19.7M vs 13M

Q2.24

+23%

19.5M vs 15.8M

Q3.24

+26%

23M vs 18.3M

Q4.24

+29%

25.1M vs 19.5M

Return on Equity

QoQ

Q1.23

-1%

-0.01
vs 0

Q2.23

+4%

0.04
vs -0.01

Q3.23

+6%

0.06
vs 0.04

Q4.23

+3%

0.03
vs 0.06

Q1.24

-4%

-0.04
vs 0.03

Q2.24

+2%

0.02
vs -0.04

Q3.24

+7%

0.07
vs 0.02

Q4.24

+3%

0.03
vs 0.07

Institutionnal Ownership

Earnings Growth

Latest News

globenewswire.com

8 hours ago

Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors

globenewswire.com

8 hours ago

Cannara Biotech Reports Q3 2024 Financial Results

globenewswire.com

9 hours ago

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

globenewswire.com

9 hours ago

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

globenewswire.com

12 hours ago

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

prnewswire.com

15 hours ago

Cannara Biotech Reports Q2 2024 Financial Results